Q² Solutions Welcomes Dr. Bob Bailer as Head of Vaccines Business Unit

Morrisville, N.C. – August 19, 2019 – Q² Solutions, a leading clinical trial laboratory services organization, announced today the addition of Dr. Bob Bailer as Head of the Vaccines Business Unit.

As Head of the Vaccines Business Unit, Dr. Bailer leads a well-established team focused on lab services to support vaccine immunogenicity and efficacy studies, viral and bacterial neutralization assays across multiple platforms, custom PCR development to support vector-specific detection, immunoassay development in ELISA and Luminex platforms, and expertise in influenza vaccine clinical trials with a full range of lab services.

“We are very excited to have Bob join our team and look forward to his contributions and positive impact to the business”, said Kevin Jones, Q² Solutions General Manager, Bioanalytical/ADME and Vaccines Laboratories. Bob’s broad and deep knowledge across science, technology, regulatory, and laboratory operations will enable him to execute on our growth strategy and provide leadership and insights for employees and customers."

Dr. Bailer joins us from the National Institute of Health (NIH) where he served as the Director of the Vaccine Immunogenicity Testing Program. Prior to the NIH, Bob held increasing roles of responsibility across pharma and US government agencies. Bob obtained his undergraduate degree in Microbiology from Colorado State University, and his Ph.D. in Viral Immunology from The Ohio State University.

Click here to learn more about Q² Solutions clinical vaccine laboratory services.


About Q² Solutions
Q² Solutions is a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions. With a relentless focus on quality and innovation, Q² Solutions uses its global experience and scientific expertise to transform science and data into actionable medical insights that help customers improve human health. A joint venture of IQVIA (formerly QuintilesIMS) and Quest Diagnostics, Q² Solutions combines the best of each parent organization’s clinical trials laboratory services capabilities to fulfill its mission of treating each sample as if a life depends on it. To learn more, visit www.q2labsolutions.com.